ATBPF - Antibe Therapeutics Inc. GAAP EPS of -$0.50 misses by $0.06
- Antibe Therapeutics Inc. press release ( OTCQX:ATBPF ): FY GAAP EPS of -$0.50 misses by $0.06 .
- As of March 31, 2022, the Company had an available cash balance and term deposits totaling $54.8 million, compared to $72.0 million as at March 31, 2021.
For further details see:
Antibe Therapeutics Inc. GAAP EPS of -$0.50 misses by $0.06